| |
| |
|
| Insider
Information: |
Tsuchimoto Kim R |
| Relationship: |
Chief Financial Office... |
| City: |
Novato |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
52,970 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$33,926 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
52,970 |
|
|
| Total
Value |
$33,926 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Raptor Pharmaceuticals Corp. |
RPTP |
CFO, Secretary & Treas... |
2007-05-17 |
2,500 |
2007-05-17 |
0 |
Premium* |
|
|
Monopar Therapeutics |
MNPR |
Chief Financial Office... |
2024-03-31 |
50,470 |
2019-12-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
32 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MNPR |
Monopar Therapeutics |
Chief Financial Officer |
• – – |
2019-12-18 |
4 |
B |
$8.00 |
$2,600 |
D/D |
325 |
325 |
0.01 |
- |
|
| MNPR |
Monopar Therapeutics |
Chief Financial Officer |
• – – |
2021-01-01 |
4 |
D |
$6.12 |
$3,084 |
D/D |
(504) |
1,052 |
0 |
- |
|
| MNPR |
Monopar Therapeutics |
Chief Financial Officer |
• – – |
2021-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,231 |
1,556 |
0 |
- |
|
| MNPR |
Monopar Therapeutics |
Chief Financial Officer |
• – – |
2021-06-30 |
4 |
D |
$5.89 |
$4,847 |
D/D |
(823) |
2,671 |
0 |
- |
|
| MNPR |
Monopar Therapeutics |
Chief Financial Officer |
• – – |
2021-06-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,442 |
3,494 |
0 |
- |
|
| MNPR |
Monopar Therapeutics |
Chief Financial Officer |
• – – |
2021-09-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,221 |
3,892 |
0 |
- |
|
| MNPR |
Monopar Therapeutics |
Chief Financial Officer |
• – – |
2021-09-30 |
4 |
D |
$4.87 |
$2,060 |
D/D |
(423) |
3,469 |
0 |
- |
|
| MNPR |
Monopar Therapeutics |
Chief Financial Officer |
• – – |
2021-12-31 |
4 |
D |
$3.21 |
$1,608 |
D/D |
(501) |
4,189 |
0 |
- |
|
| MNPR |
Monopar Therapeutics |
Chief Financial Officer |
• – – |
2021-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,221 |
4,690 |
0 |
- |
|
| MNPR |
Monopar Therapeutics |
Chief Financial Officer |
• – – |
2022-01-01 |
4 |
D |
$3.21 |
$1,621 |
D/D |
(505) |
4,915 |
0 |
- |
|
| MNPR |
Monopar Therapeutics |
Chief Financial Officer |
• – – |
2022-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,231 |
5,420 |
0 |
- |
|
| MNPR |
Monopar Therapeutics |
Chief Financial Officer |
• – – |
2022-03-31 |
4 |
D |
$2.55 |
$1,275 |
D/D |
(500) |
5,636 |
0 |
- |
|
| MNPR |
Monopar Therapeutics |
Chief Financial Officer |
• – – |
2022-03-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,221 |
6,136 |
0 |
- |
|
| MNPR |
Monopar Therapeutics |
Chief Financial Officer |
• – – |
2022-06-30 |
4 |
D |
$2.30 |
$7,088 |
D/D |
(3,083) |
11,466 |
0 |
- |
|
| MNPR |
Monopar Therapeutics |
Chief Financial Officer |
• – – |
2022-06-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,913 |
14,549 |
0 |
- |
|
| MNPR |
Monopar Therapeutics |
Chief Financial Officer |
• – – |
2022-09-30 |
4 |
D |
$1.52 |
$2,665 |
D/D |
(1,753) |
14,779 |
0 |
- |
|
| MNPR |
Monopar Therapeutics |
Chief Financial Officer |
• – – |
2022-09-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,066 |
16,532 |
0 |
- |
|
| MNPR |
Monopar Therapeutics |
Chief Financial Officer |
• • – |
2022-12-31 |
4 |
D |
$2.37 |
$4,899 |
D/D |
(2,067) |
17,779 |
0 |
- |
|
| MNPR |
Monopar Therapeutics |
Chief Financial Officer |
• • – |
2022-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,067 |
19,846 |
0 |
- |
|
| MNPR |
Monopar Therapeutics |
Chief Financial Officer |
• • – |
2023-01-01 |
4 |
D |
$2.37 |
$1,190 |
D/D |
(502) |
18,507 |
0 |
- |
|
| MNPR |
Monopar Therapeutics |
Chief Financial Officer |
• • – |
2023-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,230 |
19,009 |
0 |
- |
|
| MNPR |
Monopar Therapeutics |
Chief Financial Officer |
• • – |
2023-06-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,846 |
36,578 |
0 |
- |
|
| MNPR |
Monopar Therapeutics |
Chief Financial Officer |
• • – |
2023-06-30 |
4 |
D |
$0.86 |
$4,364 |
D/D |
(5,104) |
31,474 |
0 |
- |
|
| MNPR |
Monopar Therapeutics |
Chief Financial Officer |
• • – |
2023-09-30 |
4 |
D |
$0.62 |
$2,135 |
D/D |
(3,444) |
37,986 |
0 |
- |
|
| MNPR |
Monopar Therapeutics |
Chief Financial Officer |
• • – |
2023-09-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,956 |
41,430 |
0 |
- |
|
32 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
